MedPath

A Phase II, long-term, extension study of DS-5141b in Patients With Duchenne Muscular Dystrophy

Phase 2
Completed
Conditions
Duchenne muscular dystrophy
Registration Number
JPRN-jRCT2080225225
Lead Sponsor
DAIICHI SANKYO Co.,Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
Male
Target Recruitment
8
Inclusion Criteria

Has competed a study of DS5141-A-J101.

Exclusion Criteria

1) Significant safety issues in a study of DS5141-A-J101
2) Patient who does not consent to use appropriate contraception
3) Patient who was judged by the investigator that is not appropriate to participate in this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath